Homologous recombination-mediated irreversible genome damage underlies telomere-induced senescence.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
18 11 2021
Historique:
accepted: 12 10 2021
revised: 28 09 2021
received: 18 08 2020
pubmed: 3 11 2021
medline: 28 12 2021
entrez: 2 11 2021
Statut: ppublish

Résumé

Loss of telomeric DNA leads to telomere uncapping, which triggers a persistent, p53-centric DNA damage response that sustains a stable senescence-associated proliferation arrest. Here, we show that in normal cells telomere uncapping triggers a focal telomeric DNA damage response accompanied by a transient cell cycle arrest. Subsequent cell division with dysfunctional telomeres resulted in sporadic telomeric sister chromatid fusions that gave rise to next-mitosis genome instability, including non-telomeric DNA lesions responsible for a stable, p53-mediated, senescence-associated proliferation arrest. Unexpectedly, the blocking of Rad51/RPA-mediated homologous recombination, but not non-homologous end joining (NHEJ), prevented senescence despite multiple dysfunctional telomeres. When cells approached natural replicative senescence, interphase senescent cells displayed genome instability, whereas near-senescent cells that underwent mitosis despite the presence of uncapped telomeres did not. This suggests that these near-senescent cells had not yet acquired irreversible telomeric fusions. We propose a new model for telomere-initiated senescence where tolerance of telomere uncapping eventually results in irreversible non-telomeric DNA lesions leading to stable senescence. Paradoxically, our work reveals that senescence-associated tumor suppression from telomere shortening requires irreversible genome instability at the single-cell level, which suggests that interventions to repair telomeres in the pre-senescent state could prevent senescence and genome instability.

Identifiants

pubmed: 34725692
pii: 6414056
doi: 10.1093/nar/gkab965
pmc: PMC8599762
doi:

Substances chimiques

RAD51 protein, human EC 2.7.7.-
Rad51 Recombinase EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11690-11707

Subventions

Organisme : CIHR
ID : MOP114962
Pays : Canada

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

J Cell Biol. 2011 Feb 21;192(4):547-56
pubmed: 21321098
Aging (Albany NY). 2012 Jun;4(6):431-5
pubmed: 22745179
EMBO J. 2002 Aug 15;21(16):4338-48
pubmed: 12169636
Science. 2002 Jul 26;297(5581):565-9
pubmed: 12142527
Cell Death Dis. 2013 Jun 27;4:e691
pubmed: 23807220
Mol Cell Biol. 2009 Oct;29(20):5552-63
pubmed: 19667071
J Cell Sci. 2011 Jan 1;124(Pt 1):68-81
pubmed: 21118958
Genome Res. 2016 May;26(5):588-600
pubmed: 26941250
PLoS One. 2016 May 17;11(5):e0155725
pubmed: 27187621
Nucleic Acids Res. 2013 Jan;41(2):900-11
pubmed: 23193277
Nat Cell Biol. 2008 Jul;10(7):825-36
pubmed: 18516091
Cold Spring Harb Symp Quant Biol. 1993;58:719-23
pubmed: 7525147
Mol Cell. 2004 May 21;14(4):501-13
pubmed: 15149599
Curr Biol. 2003 Sep 2;13(17):1549-56
pubmed: 12956959
Cell. 2017 Jun 1;169(6):1000-1011
pubmed: 28575665
Cell. 1993 Nov 19;75(4):729-39
pubmed: 8242745
Mol Cell Biol. 2015 Oct 26;36(1):210-22
pubmed: 26503784
Nat Cell Biol. 2012 Mar 18;14(4):355-65
pubmed: 22426077
EMBO Rep. 2011 Dec 23;13(1):52-9
pubmed: 22157895
EMBO J. 2010 Aug 4;29(15):2598-610
pubmed: 20588252
Cell Metab. 2020 Nov 3;32(5):814-828.e6
pubmed: 32949498
Curr Opin Cell Biol. 2012 Dec;24(6):731-8
pubmed: 22947495
Nature. 2011 Nov 02;479(7372):232-6
pubmed: 22048312
Nat Commun. 2016 Mar 04;7:10881
pubmed: 26941064
Proc Natl Acad Sci U S A. 1963 Aug;50:390-5
pubmed: 14060661
Cell Cycle. 2004 Oct;3(10):1217-20
pubmed: 15467458
EMBO J. 2020 Dec 1;39(23):e104500
pubmed: 33073402
J Cell Biol. 2008 May 5;181(3):447-60
pubmed: 18443218
Science. 1989 Nov 3;246(4930):629-34
pubmed: 2683079
Sci Rep. 2016 Oct 12;6:35218
pubmed: 27731420
Nature. 2000 Aug 10;406(6796):641-5
pubmed: 10949306
Cell. 2008 Aug 22;134(4):657-67
pubmed: 18724938
EMBO J. 2007 Nov 14;26(22):4709-19
pubmed: 17948054
Exp Cell Res. 1975 Nov;96(1):1-6
pubmed: 1193162
Mol Cell. 2012 Aug 24;47(4):497-510
pubmed: 22920291
Nat Cell Biol. 2010 Jul;12(7):676-85
pubmed: 20526329
EMBO J. 2005 Jul 20;24(14):2667-78
pubmed: 15973431
Science. 2014 Apr 11;344(6180):189-93
pubmed: 24652939
Aging Cell. 2013 Aug;12(4):622-34
pubmed: 23590226
J Biol Chem. 2011 Oct 21;286(42):36396-403
pubmed: 21880712
Nature. 2014 May 22;509(7501):439-46
pubmed: 24848057
Exp Cell Res. 2000 Apr 10;256(1):291-9
pubmed: 10739676
Trends Cell Biol. 2001 Nov;11(11):S27-31
pubmed: 11684439
Nat Commun. 2018 Jul 19;9(1):2834
pubmed: 30026603
Nature. 2007 Aug 30;448(7157):1068-71
pubmed: 17687332
Mol Cell. 2013 Jul 25;51(2):141-55
pubmed: 23850488
Mech Ageing Dev. 2007 Jan;128(1):36-44
pubmed: 17116315
Cell Cycle. 2019 Apr;18(8):880-888
pubmed: 30907229
PLoS One. 2009 Aug 06;4(8):e6529
pubmed: 19657394
Nat Commun. 2012 Feb 28;3:708
pubmed: 22426229
Genes Dev. 2018 Dec 1;32(23-24):1499-1513
pubmed: 30463903
Annu Rev Genet. 2008;42:301-34
pubmed: 18680434
Nucleic Acids Res. 2010 Apr;38(6):1841-52
pubmed: 20026586
Proc Natl Acad Sci U S A. 1988 Dec;85(23):9086-90
pubmed: 3194411
Curr Biol. 2002 Oct 1;12(19):1635-44
pubmed: 12361565
Dev Cell. 2017 Jun 19;41(6):638-651.e5
pubmed: 28633018
Nat Struct Mol Biol. 2012 Mar 11;19(4):387-94
pubmed: 22407014
Nat Commun. 2019 Jun 11;10(1):2556
pubmed: 31186408
Nat Commun. 2014 Oct 31;5:5379
pubmed: 25359189
EMBO J. 2009 Nov 4;28(21):3390-9
pubmed: 19763083
J Invest Dermatol. 2015 Jul;135(7):1722-1726
pubmed: 25855157
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
Mol Cell. 2005 Nov 23;20(4):551-61
pubmed: 16307919
Nucleic Acids Res. 2012 Jul;40(13):5795-818
pubmed: 22467216
EMBO J. 2003 Aug 15;22(16):4212-22
pubmed: 12912919
Transl Cancer Res. 2013 Jun;2(3):130-143
pubmed: 24000320
Mol Cell Biol. 1998 Mar;18(3):1611-21
pubmed: 9488478
Semin Immunol. 2018 Dec;40:101275
pubmed: 31088710
Cell. 1998 Feb 6;92(3):401-13
pubmed: 9476899
Biochem Biophys Res Commun. 1984 Aug 30;123(1):291-8
pubmed: 6477583
Nat Cell Biol. 2009 Aug;11(8):973-9
pubmed: 19597488
Nat Commun. 2015 Jul 09;6:7680
pubmed: 26158780
Cell. 1999 May 14;97(4):503-14
pubmed: 10338214
Curr Opin Genet Dev. 2014 Jun;26:89-95
pubmed: 25104620
Genes Dev. 2007 Oct 1;21(19):2495-508
pubmed: 17908935
Front Biosci. 2008 Jan 01;13:2075-90
pubmed: 17981693
FASEB J. 2003 Mar;17(3):333-40
pubmed: 12631573
J Biol Chem. 2004 Oct 15;279(42):43799-804
pubmed: 15292264
Am J Hum Genet. 1976 Sep;28(5):465-73
pubmed: 984042
Nature. 2016 Feb 11;530(7589):184-9
pubmed: 26840489
Mol Biol Cell. 2004 Aug;15(8):3709-18
pubmed: 15181152
Cell Rep. 2017 Jun 6;19(10):2060-2073
pubmed: 28591578
Nature. 2003 Nov 13;426(6963):194-8
pubmed: 14608368
Nature. 1998 Apr 9;392(6676):569-74
pubmed: 9560153

Auteurs

Sabrina Ghadaouia (S)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.

Marc-Alexandre Olivier (MA)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.

Aurélie Martinez (A)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.

Tibila Kientega (T)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.

Jian Qin (J)

Department of Anatomy and Cell Biology, McGill University, Montreal, QC, H3A 0C7, Canada.
Jewish General Hospital, Lady Davis Institute, Montreal, QC, H3T 1E2, Canada.

Patrick Lambert-Lanteigne (P)

Jewish General Hospital, Lady Davis Institute, Montreal, QC, H3T 1E2, Canada.

Guillaume B Cardin (GB)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.

Chantal Autexier (C)

Department of Anatomy and Cell Biology, McGill University, Montreal, QC, H3A 0C7, Canada.
Jewish General Hospital, Lady Davis Institute, Montreal, QC, H3T 1E2, Canada.

Nicolas Malaquin (N)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.

Francis Rodier (F)

Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.
Institut du cancer de Montréal, Montreal, QC, H2X 0A9, Canada.
Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montreal, QC, H3T 1J4, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH